Advertisement

Colorectal Cancer Research: A State of the Art

  • Nicola de’Angelis
Chapter
Part of the Hot Topics in Acute Care Surgery and Trauma book series (HTACST)

Abstract

In the last two decades, research in colorectal cancer has enormously advanced. Progress in screening and diagnosis, neoadjuvant and adjuvant treatments, and surgical techniques contributed to improve patient’s survival even for advanced stages of disease. However, much more remains to be done. Research gaps are identified in colorectal cancer etiology, molecular and biological mechanisms, about the role of intestinal microbiome and the capacity of predicting treatment responses and apply a personalized medicine. Furthermore, efforts are expected to improve the quality of life of patients that live with or beyond colorectal cancer.

Keywords

Colorectal cancer Colorectal surgery Emergency surgery Research Evidence-based medicine 

References

  1. 1.
    Global Burden of Disease Cancer, C, Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, Brenner H, Dicker DJ, Chimed-Orchir O, Dandona R, Dandona L, Fleming T, Forouzanfar MH, Hancock J, Hay RJ, Hunter-Merrill R, Huynh C, Hosgood HD, Johnson CO, Jonas JB, Khubchandani J, Kumar GA, Kutz M, Lan Q, Larson HJ, Liang X, Lim SS, Lopez AD, MF MI, Marczak L, Marquez N, Mokdad AH, Pinho C, Pourmalek F, Salomon JA, Sanabria JR, Sandar L, Sartorius B, Schwartz SM, Shackelford KA, Shibuya K, Stanaway J, Steiner C, Sun J, Takahashi K, Vollset SE, Vos T, Wagner JA, Wang H, Westerman R, Zeeb H, Zoeckler L, Abd-Allah F, Ahmed MB, Alabed S, Alam NK, Aldhahri SF, Alem G, Alemayohu MA, Ali R, Al-Raddadi R, Amare A, Amoako Y, Artaman A, Asayesh H, Atnafu N, Awasthi A, Saleem HB, Barac A, Bedi N, Bensenor I, Berhane A, Bernabe E, Betsu B, Binagwaho A, Boneya D, Campos-Nonato I, Castaneda-Orjuela C, Catala-Lopez F, Chiang P, Chibueze C, Chitheer A, Choi JY, Cowie B, Damtew S, das Neves J, Dey S, Dharmaratne S, Dhillon P, Ding E, Driscoll T, Ekwueme D, Endries AY, Farvid M, Farzadfar F, Fernandes J, Fischer F, GH TT, Gebru A, Gopalani S, Hailu A, Horino M, Horita N, Husseini A, Huybrechts I, Inoue M, Islami F, Jakovljevic M, James S, Javanbakht M, Jee SH, Kasaeian A, Kedir MS, Khader YS, Khang YH, Kim D, Leigh J, Linn S, Lunevicius R, HMA ER, Malekzadeh R, Malta DC, Marcenes W, Markos D, Melaku YA, Meles KG, Mendoza W, Mengiste DT, Meretoja TJ, Miller TR, Mohammad KA, Mohammadi A, Mohammed S, Moradi-Lakeh M, Nagel G, Nand D, Le Nguyen Q, Nolte S, Ogbo FA, Oladimeji KE, Oren E, Pa M, Park EK, Pereira DM, Plass D, Qorbani M, Radfar A, Rafay A, Rahman M, Rana SM, Soreide K, Satpathy M, Sawhney M, Sepanlou SG, Shaikh MA, She J, Shiue I, Shore HR, Shrime MG, So S, Soneji S, Stathopoulou V, Stroumpoulis K, Sufiyan MB, Sykes BL, Tabares-Seisdedos R, Tadese F, Tedla BA, Tessema GA, Thakur JS, Tran BX, Ukwaja KN, BSC U, Vlassov VV, Weiderpass E, Wubshet Terefe M, Yebyo HG, Yimam HH, Yonemoto N, Younis MZ, Yu C, Zaidi Z, MES Z, Zenebe ZM, CJL M, Naghavi M. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol. 2017;3(4):524–48.CrossRefGoogle Scholar
  2. 2.
    Connell LC, Mota JM, Braghiroli MI, Hoff PM. The rising incidence of younger patients with colorectal cancer: questions about screening, biology, and treatment. Curr Treat Options Oncol. 2017;18(4):23.PubMedCrossRefGoogle Scholar
  3. 3.
    Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2017;66(4):683–91.PubMedCrossRefGoogle Scholar
  4. 4.
    TAC Society. Global cancer control work. 2018. Accessed 8 May, 2018.Google Scholar
  5. 5.
    Heinemann V, von Weikersthal LF, Decker T, Kiani A, Vehling-Kaiser U, Al-Batran SE, Heintges T, Lerchenmuller C, Kahl C, Seipelt G, Kullmann F, Stauch M, Scheithauer W, Hielscher J, Scholz M, Muller S, Link H, Niederle N, Rost A, Hoffkes HG, Moehler M, Lindig RU, Modest DP, Rossius L, Kirchner T, Jung A, Stintzing S. FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial. Lancet Oncol. 2014;15(10):1065–75.PubMedCrossRefGoogle Scholar
  6. 6.
    Center MM, Jemal A, Smith RA, Ward E. Worldwide variations in colorectal cancer. CA Cancer J Clin. 2009;59(6):366–78.CrossRefGoogle Scholar
  7. 7.
    Henry KA, Niu X, Boscoe FP. Geographic disparities in colorectal cancer survival. Int J Health Geogr. 2009;8:48.PubMedPubMedCentralCrossRefGoogle Scholar
  8. 8.
    Lian M, Schootman M, Doubeni CA, Park Y, Major JM, Stone RA, Laiyemo AO, Hollenbeck AR, Graubard BI, Schatzkin A. Geographic variation in colorectal cancer survival and the role of small-area socioeconomic deprivation: a multilevel survival analysis of the NIH-AARP diet and health study cohort. Am J Epidemiol. 2011;174(7):828–38.PubMedPubMedCentralCrossRefGoogle Scholar
  9. 9.
    Favoriti P, Carbone G, Greco M, Pirozzi F, Pirozzi RE, Corcione F. Worldwide burden of colorectal cancer: a review. Updates Surg. 2016;68(1):7–11.PubMedCrossRefGoogle Scholar
  10. 10.
    ASoC Oncology. Cancer progress timeline. 2018.Google Scholar
  11. 11.
    Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM, Bos JL. Genetic alterations during colorectal-tumor development. N Engl J Med. 1988;319(9):525–32.CrossRefGoogle Scholar
  12. 12.
    Huxley RR, Ansary-Moghaddam A, Clifton P, Czernichow S, Parr CL, Woodward M. The impact of dietary and lifestyle risk factors on risk of colorectal cancer: a quantitative overview of the epidemiological evidence. Int J Cancer. 2009;125(1):171–80.PubMedCrossRefGoogle Scholar
  13. 13.
    Crosara Teixeira M, Braghiroli MI, Sabbaga J, Hoff PM. Primary prevention of colorectal cancer: myth or reality? World J Gastroenterol. 2014;20(41):15060–9.PubMedPubMedCentralCrossRefGoogle Scholar
  14. 14.
    Massat NJ, Moss SM, Halloran SP, Duffy SW. Screening and primary prevention of colorectal cancer: a review of sex-specific and site-specific differences. J Med Screen. 2013;20(3):125–48.PubMedCrossRefGoogle Scholar
  15. 15.
    Schoenberg MH. Physical activity and nutrition in primary and tertiary prevention of colorectal cancer. Visc Med. 2016;32(3):199–204.PubMedPubMedCentralCrossRefGoogle Scholar
  16. 16.
    Winawer SJ. The history of colorectal cancer screening: a personal perspective. Dig Dis Sci. 2015;60(3):596–608.PubMedCrossRefGoogle Scholar
  17. 17.
    ACS Reccomandations. Colorectal cancer early detection 2017.Google Scholar
  18. 18.
    Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, Ederer F. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med. 1993;328(19):1365–71.PubMedCrossRefGoogle Scholar
  19. 19.
    Yang DX, Gross CP, Soulos PR, Yu JB. Estimating the magnitude of colorectal cancers prevented during the era of screening: 1976 to 2009. Cancer. 2014;120(18):2893–901.PubMedCrossRefGoogle Scholar
  20. 20.
    Andre T, Boni C, Navarro M, Tabernero J, Hickish T, Topham C, Bonetti A, Clingan P, Bridgewater J, Rivera F, de Gramont A. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol. 2009;27(19):3109–16.PubMedCrossRefGoogle Scholar
  21. 21.
    Grothey A, Van Cutsem E, Sobrero A, Siena S, Falcone A, Ychou M, Humblet Y, Bouche O, Mineur L, Barone C, Adenis A, Tabernero J, Yoshino T, Lenz HJ, Goldberg RM, Sargent DJ, Cihon F, Cupit L, Wagner A, Laurent D, Group, CS. Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial. Lancet. 2013;381(9863):303–12.PubMedPubMedCentralCrossRefGoogle Scholar
  22. 22.
    Karapetis CS, Khambata-Ford S, Jonker DJ, O’Callaghan CJ, Tu D, Tebbutt NC, Simes RJ, Chalchal H, Shapiro JD, Robitaille S, Price TJ, Shepherd L, Au HJ, Langer C, Moore MJ, Zalcberg JR. K-ras mutations and benefit from cetuximab in advanced colorectal cancer. N Engl J Med. 2008;359(17):1757–65.CrossRefGoogle Scholar
  23. 23.
    G Foxtrot Collaborative. Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: the pilot phase of a randomised controlled trial. Lancet Oncol. 2012;13(11):1152–60.CrossRefGoogle Scholar
  24. 24.
    Dragani TA, Castells A, Kulasingam V, Diamandis EP, Earl H, Iams WT, Lovly CM, Sedelaar JP, Schalken JA. Major milestones in translational oncology. BMC Med. 2016;14(1):110.PubMedPubMedCentralCrossRefGoogle Scholar
  25. 25.
    Guinney J, Dienstmann R, Wang X, de Reynies A, Schlicker A, Soneson C, Marisa L, Roepman P, Nyamundanda G, Angelino P, Bot BM, Morris JS, Simon IM, Gerster S, Fessler E, De Sousa EMF, Missiaglia E, Ramay H, Barras D, Homicsko K, Maru D, Manyam GC, Broom B, Boige V, Perez-Villamil B, Laderas T, Salazar R, Gray JW, Hanahan D, Tabernero J, Bernards R, Friend SH, Laurent-Puig P, Medema JP, Sadanandam A, Wessels L, Delorenzi M, Kopetz S, Vermeulen L, Tejpar S. The consensus molecular subtypes of colorectal cancer. Nat Med. 2015;21(11):1350–6.PubMedPubMedCentralCrossRefGoogle Scholar
  26. 26.
    N Cancer Genome Atlas. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487(7407):330–7.CrossRefGoogle Scholar
  27. 27.
    Le DT, Uram JN, Wang H, Bartlett BR, Kemberling H, Eyring AD, Skora AD, Luber BS, Azad NS, Laheru D, Biedrzycki B, Donehower RC, Zaheer A, Fisher GA, Crocenzi TS, Lee JJ, Duffy SM, Goldberg RM, de la Chapelle A, Koshiji M, Bhaijee F, Huebner T, Hruban RH, Wood LD, Cuka N, Pardoll DM, Papadopoulos N, Kinzler KW, Zhou S, Cornish TC, Taube JM, Anders RA, Eshleman JR, Vogelstein B, Diaz LA Jr. PD-1 blockade in tumors with mismatch-repair deficiency. N Engl J Med. 2015;372(26):2509–20.PubMedPubMedCentralCrossRefGoogle Scholar
  28. 28.
    Initial report from a Swedish multicentre study examining the role of preoperative irradiation in the treatment of patients with resectable rectal carcinoma. Swedish Rectal Cancer Trial. Br J Surg. 1993;80(10):1333–6.Google Scholar
  29. 29.
    Kye BH, Cho HM. Overview of radiation therapy for treating rectal cancer. Ann Coloproctol. 2014;30(4):165–74.PubMedPubMedCentralCrossRefGoogle Scholar
  30. 30.
    Dahlberg M, Glimelius B, Graf W, Pahlman L. Preoperative irradiation affects functional results after surgery for rectal cancer: results from a randomized study. Dis Colon Rectum. 1998;41(5):543–9. discussion 549–551.CrossRefGoogle Scholar
  31. 31.
    Kong JC, Guerra GR, Warrier SK, Ramsay RG, Heriot AG. Outcome and salvage surgery following “watch and wait” for rectal cancer after neoadjuvant therapy: a systematic review. Dis Colon Rectum. 2017;60(3):335–45.PubMedGoogle Scholar
  32. 32.
    Nakagawa WT, Rossi BM, de OFF, Ferrigno R, David Filho WJ, Nishimoto IN, Vieira RA, Lopes A. Chemoradiation instead of surgery to treat mid and low rectal tumors: is it safe? Ann Surg Oncol. 2002;9(6):568–73.PubMedCrossRefGoogle Scholar
  33. 33.
    Habr-Gama A, Perez RO, Nadalin W, Sabbaga J, Ribeiro U Jr, Silva e Sousa AH Jr, Campos FG, Kiss DR, Gama-Rodrigues J. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg. 2004;240(4):711–7. discussion 717–718.Google Scholar
  34. 34.
    Hendren SK, O’Connor BI, Liu M, Asano T, Cohen Z, Swallow CJ, Macrae HM, Gryfe R, McLeod RS. Prevalence of male and female sexual dysfunction is high following surgery for rectal cancer. Ann Surg. 2005;242(2):212–23.PubMedPubMedCentralCrossRefGoogle Scholar
  35. 35.
    Chen TY, Wiltink LM, Nout RA, Meershoek-Klein Kranenbarg E, Laurberg S, Marijnen CA, van de Velde CJ. Bowel function 14 years after preoperative short-course radiotherapy and total mesorectal excision for rectal cancer: report of a multicenter randomized trial. Clin Colorectal Cancer. 2015;14(2):106–14.PubMedCrossRefGoogle Scholar
  36. 36.
    Lawler M, Alsina D, Adams RA, Anderson AS, Brown G, Fearnhead NS, Fenwick SW, Halloran SP, Hochhauser D, Hull MA, Koelzer VH, McNair AGK, Monahan KJ, Nathke I, Norton C, Novelli MR, Steele RJC, Thomas AL, Wilde LM, Wilson RH, Tomlinson I, Bowel Cancer, UKCRGiCCI. Critical research gaps and recommendations to inform research prioritisation for more effective prevention and improved outcomes in colorectal cancer. Gut. 2018;67(1):179–93.PubMedCrossRefGoogle Scholar
  37. 37.
    Raskov H, Burcharth J, Pommergaard HC. Linking gut microbiota to colorectal cancer. J Cancer. 2017;8(17):3378–95.PubMedPubMedCentralCrossRefGoogle Scholar
  38. 38.
    Weinberg DS, Myers RE, Keenan E, Ruth K, Sifri R, Ziring B, Ross E, Manne SL. Genetic and environmental risk assessment and colorectal cancer screening in an average-risk population: a randomized trial. Ann Intern Med. 2014;161(8):537–45.PubMedPubMedCentralCrossRefGoogle Scholar
  39. 39.
    Andreyev J. Gastrointestinal symptoms after pelvic radiotherapy: a new understanding to improve management of symptomatic patients. Lancet Oncol. 2007;8(11):1007–17.PubMedCrossRefGoogle Scholar
  40. 40.
    Battersby NJ, Juul T, Christensen P, Janjua AZ, Branagan G, Emmertsen KJ, Norton C, Hughes R, Laurberg S, Moran BJ, United Kingdom Low Anterior Resection Syndrome Study, G. Predicting the risk of bowel-related quality-of-life impairment after restorative resection for rectal cancer: a multicenter cross-sectional study. Dis Colon Rectum. 2016;59(4):270–80.PubMedCrossRefGoogle Scholar
  41. 41.
    Scheer AS, Boushey RP, Liang S, Doucette S, O’Connor AM, Moher D. The long-term gastrointestinal functional outcomes following curative anterior resection in adults with rectal cancer: a systematic review and meta-analysis. Dis Colon Rectum. 2011;54(12):1589–97.PubMedCrossRefGoogle Scholar
  42. 42.
    Dietz DW, Consortium for Optimizing Surgical Treatment of Rectal, C. Multidisciplinary management of rectal cancer: the OSTRICH. J Gastrointest Surg. 2013;17(10):1863–8.PubMedCrossRefGoogle Scholar
  43. 43.
    Sondenaa K, Quirke P, Hohenberger W, Sugihara K, Kobayashi H, Kessler H, Brown G, Tudyka V, D’Hoore A, Kennedy RH, West NP, Kim SH, Heald R, Storli KE, Nesbakken A, Moran B. The rationale behind complete mesocolic excision (CME) and a central vascular ligation for colon cancer in open and laparoscopic surgery: proceedings of a consensus conference. Int J Colorectal Dis. 2014;29(4):419–28.PubMedCrossRefGoogle Scholar
  44. 44.
    West NP, Hohenberger W, Weber K, Perrakis A, Finan PJ, Quirke P. Complete mesocolic excision with central vascular ligation produces an oncologically superior specimen compared with standard surgery for carcinoma of the colon. J Clin Oncol. 2010;28(2):272–8.PubMedCrossRefGoogle Scholar
  45. 45.
    de’Angelis N, Alghamdi S, Renda A, Azoulay D, Brunetti F. Initial experience of robotic versus laparoscopic colectomy for transverse colon cancer: a matched case-control study. World J Surg Oncol. 2015;13:295.PubMedPubMedCentralCrossRefGoogle Scholar
  46. 46.
    de’Angelis N, Hain E, Disabato M, Cordun C, Carra MC, Azoulay D, Brunetti F. Laparoscopic extended right colectomy versus laparoscopic left colectomy for carcinoma of the splenic flexure: a matched case-control study. Int J Colorectal Dis. 2016;31(3):623–30.PubMedCrossRefGoogle Scholar
  47. 47.
    Martinez-Perez A, Brunetti F, Vitali GC, Abdalla S, Ris F, de’Angelis N. Surgical treatment of colon cancer of the splenic flexure: a systematic review and meta-analysis. Surg Laparosc Endosc Percutan Tech. 2017;27(5):318–27.PubMedCrossRefGoogle Scholar
  48. 48.
    Galler AS, Petrelli NJ, Shakamuri SP. Rectal cancer surgery: a brief history. Surg Oncol. 2011;20(4):223–30.PubMedCrossRefGoogle Scholar
  49. 49.
    Heald RJ, Moran BJ, Ryall RD, Sexton R, MacFarlane JK. Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997. Arch Surg. 1998;133(8):894–9.PubMedCrossRefGoogle Scholar
  50. 50.
    Carlsen E, Schlichting E, Guldvog I, Johnson E, Heald RJ. Effect of the introduction of total mesorectal excision for the treatment of rectal cancer. Br J Surg. 1998;85(4):526–9.PubMedCrossRefGoogle Scholar
  51. 51.
    Stewart DB, Dietz DW. Total mesorectal excision: what are we doing? Clin Colon Rectal Surg. 2007;20(3):190–202.PubMedPubMedCentralCrossRefGoogle Scholar
  52. 52.
    Abu Gazala M, Wexner SD. Re-appraisal and consideration of minimally invasive surgery in colorectal cancer. Gastroenterol Rep (Oxf). 2017;5(1):1–10.CrossRefGoogle Scholar
  53. 53.
    Martinez-Perez A, Carra MC, Brunetti F, de’Angelis N. Short-term clinical outcomes of laparoscopic vs open rectal excision for rectal cancer: a systematic review and meta-analysis. World J Gastroenterol. 2017;23(44):7906–16.PubMedPubMedCentralCrossRefGoogle Scholar
  54. 54.
    Vennix S, Pelzers L, Bouvy N, Beets GL, Pierie JP, Wiggers T, Breukink S. Laparoscopic versus open total mesorectal excision for rectal cancer. Cochrane Database Syst Rev. 2014;(4):CD005200.Google Scholar
  55. 55.
    Veldkamp R, Kuhry E, Hop WC, Jeekel J, Kazemier G, Bonjer HJ, Haglind E, Pahlman L, Cuesta MA, Msika S, Morino M, Lacy AM, Group, COcLoORS. Laparoscopic surgery versus open surgery for colon cancer: short-term outcomes of a randomised trial. Lancet Oncol. 2005;6(7):477–84.PubMedCrossRefGoogle Scholar
  56. 56.
    Fleshman J, Branda M, Sargent DJ, Boller AM, George V, Abbas M, Peters WR Jr, Maun D, Chang G, Herline A, Fichera A, Mutch M, Wexner S, Whiteford M, Marks J, Birnbaum E, Margolin D, Larson D, Marcello P, Posner M, Read T, Monson J, Wren SM, Pisters PW, Nelson H. Effect of laparoscopic-assisted resection vs open resection of stage II or III rectal cancer on pathologic outcomes: the ACOSOG Z6051 randomized clinical trial. JAMA. 2015;314(13):1346–55.PubMedPubMedCentralCrossRefGoogle Scholar
  57. 57.
    Martinez-Perez A, Carra MC, Brunetti F, de’Angelis N. Pathologic outcomes of laparoscopic vs open mesorectal excision for rectal cancer: a systematic review and meta-analysis. JAMA Surg. 2017;152(4):e165665.PubMedCrossRefGoogle Scholar
  58. 58.
    Petrucciani N, Martinez-Perez A, Bianchi G, Memeo R, Brunetti F, De’ Angelis N. The use of laparoscopy for locally advanced rectal cancer. Minerva Chir. 2018;73(1):77–92.PubMedGoogle Scholar
  59. 59.
    Stevenson AR, Solomon MJ, Lumley JW, Hewett P, Clouston AD, Gebski VJ, Davies L, Wilson K, Hague W, Simes J, Investigators AL. Effect of laparoscopic-assisted resection vs open resection on pathological outcomes in rectal cancer: the ALaCaRT randomized clinical trial. JAMA. 2015;314(13):1356–63.PubMedCrossRefGoogle Scholar
  60. 60.
    Guillou PJ, Quirke P, Thorpe H, Walker J, Jayne DG, Smith AM, Heath RM, Brown JM, Group, MCt. Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial. Lancet. 2005;365(9472):1718–26.CrossRefGoogle Scholar
  61. 61.
    Carmichael JC, Masoomi H, Mills S, Stamos MJ, Nguyen NT. Utilization of laparoscopy in colorectal surgery for cancer at academic medical centers: does site of surgery affect rate of laparoscopy? Am Surg. 2011;77(10):1300–4.PubMedGoogle Scholar
  62. 62.
    Moghadamyeghaneh Z, Carmichael JC, Mills S, Pigazzi A, Nguyen NT, Stamos MJ. Variations in laparoscopic colectomy utilization in the united states. Dis Colon Rectum. 2015;58(10):950–6.PubMedCrossRefGoogle Scholar
  63. 63.
    Panis Y, Maggiori L, Caranhac G, Bretagnol F, Vicaut E. Mortality after colorectal cancer surgery: a French survey of more than 84,000 patients. Ann Surg. 2011;254(5):738–43. discussion 743–734.PubMedCrossRefGoogle Scholar
  64. 64.
    de’Angelis N, Felli E, Azoulay D, Brunetti F. Robotic-assisted reversal of Hartmann’s procedure for diverticulitis. J Robot Surg. 2014;8(4):381–3.PubMedPubMedCentralCrossRefGoogle Scholar
  65. 65.
    de’Angelis N, Lizzi V, Azoulay D, Brunetti F. Robotic versus laparoscopic right colectomy for colon cancer: analysis of the initial simultaneous learning curve of a surgical fellow. J Laparoendosc Adv Surg Tech A. 2016;26(11):882–92.PubMedCrossRefGoogle Scholar
  66. 66.
    Jayne D, Pigazzi A, Marshall H, Croft J, Corrigan N, Copeland J, Quirke P, West N, Rautio T, Thomassen N, Tilney H, Gudgeon M, Bianchi PP, Edlin R, Hulme C, Brown J. Effect of robotic-assisted vs conventional laparoscopic surgery on risk of conversion to open laparotomy among patients undergoing resection for rectal cancer: the ROLARR randomized clinical trial. JAMA. 2017;318(16):1569–80.PubMedPubMedCentralCrossRefGoogle Scholar
  67. 67.
    de’Angelis N, Portigliotti L, Azoulay D, Brunetti F. Robotic surgery: a step forward in the wide spread of minimally invasive colorectal surgery. J Minim Access Surg. 2015;11(4):285–6.PubMedPubMedCentralCrossRefGoogle Scholar
  68. 68.
    Yeo HL, Isaacs AJ, Abelson JS, Milsom JW, Sedrakyan A. Comparison of open, laparoscopic, and robotic colectomies using a large national database: outcomes and trends related to surgery center volume. Dis Colon Rectum. 2016;59(6):535–42.PubMedCrossRefGoogle Scholar
  69. 69.
    Meshikhes AW. Evidence-based surgery: the obstacles and solutions. Int J Surg. 2015;18:159–62.PubMedCrossRefGoogle Scholar
  70. 70.
    Felli E, Brunetti F, Disabato M, Salloum C, Azoulay D, De’angelis N. Robotic right colectomy for hemorrhagic right colon cancer: a case report and review of the literature of minimally invasive urgent colectomy. World J Emerg Surg. 2014;9:32.PubMedPubMedCentralCrossRefGoogle Scholar
  71. 71.
    Harji DP, Griffiths B, Burke D, Sagar PM. Systematic review of emergency laparoscopic colorectal resection. Br J Surg. 2014;101(1):e126–33.PubMedCrossRefGoogle Scholar
  72. 72.
    Ansaloni L, Andersson RE, Bazzoli F, Catena F, Cennamo V, Di Saverio S, Fuccio L, Jeekel H, Leppaniemi A, Moore E, Pinna AD, Pisano M, Repici A, Sugarbaker PH, Tuech JJ. Guidelines in the management of obstructing cancer of the left colon: consensus conference of the world society of emergency surgery (WSES) and peritoneum and surgery (PnS) society. World J Emerg Surg. 2010;5:29.PubMedPubMedCentralCrossRefGoogle Scholar
  73. 73.
    Chang GJ, Kaiser AM, Mills S, Rafferty JF, Buie WD, Standards Practice Task Force of the American Society of, C, and Rectal, S. Practice parameters for the management of colon cancer. Dis Colon Rectum. 2012;55(8):831–43.PubMedCrossRefGoogle Scholar
  74. 74.
    Biondo S, Kreisler E, Millan M, Fraccalvieri D, Golda T, Frago R, Miguel B. Impact of surgical specialization on emergency colorectal surgery outcomes. Arch Surg. 2010;145(1):79–86.PubMedCrossRefGoogle Scholar
  75. 75.
    Zorcolo L, Covotta L, Carlomagno N, Bartolo DC. Toward lowering morbidity, mortality, and stoma formation in emergency colorectal surgery: the role of specialization. Dis Colon Rectum. 2003;46(11):1461–7. discussion 1467–1468.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Nicola de’Angelis
    • 1
  1. 1.Unit of Digestive, Hepato-Pancreato-Biliary Surgery and Liver Transplantation, Henri Mondor Hospital, AP-HPUniversity of Paris Est, UPECCréteilFrance

Personalised recommendations